zileuton has been researched along with Cerebral Infarction, Middle Cerebral Artery in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CM; Chen, Y; Shi, SS; Tu, XK; Wang, CH; Yang, WZ | 1 |
| Chen, CM; Liang, RS; Shi, SS; Tu, XK; Wang, CH; Yang, WZ; Zhang, HB | 1 |
| Chen, CM; Shi, SS; Tu, XK; Wang, CH; Yang, WZ | 1 |
3 other study(ies) available for zileuton and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
5-Lipoxygenase inhibitor zileuton inhibits neuronal apoptosis following focal cerebral ischemia.
Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Brain; Brain Injuries; Caspase 1; Caspase 3; Hydroxyurea; Infarction, Middle Cerebral Artery; Lipoxygenase Inhibitors; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2013 |
5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Brain Ischemia; Hydroxyurea; Infarction, Middle Cerebral Artery; Inflammation; Lipoxygenase Inhibitors; Male; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction | 2016 |
5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
Topics: Animals; Arachidonate 5-Lipoxygenase; Body Water; Brain; Brain Edema; Brain Ischemia; Dose-Response Relationship, Drug; Down-Regulation; Hydroxyurea; Infarction, Middle Cerebral Artery; Lipoxygenase Inhibitors; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |